Regenerative Medical Technology (RMTG) Receivables (2021 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Receivables of $34821.0 for Q1 2026, up 113.55% year-over-year from $16306.0 in Q1 2025, and down 20.53% quarter-over-quarter from $43815.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Receivables (2021 - 2026) Analysis & Trends
Regenerative Medical Technology's Receivables history runs 6 years deep, the most recent figure standing at $34821.0 for Q1 2026.
- In Q1 2026, Receivables rose 113.55% year-over-year to $34821.0; the TTM figure through Mar 2026 stood at $34821.0 (up 113.55% YoY), while the FY2025 annual figure was $43815.0, up 93.83% from the prior year.
- Receivables for Q1 2026 stood at $34821.0, down from $43815.0 in the prior quarter.
- The five-year high for Receivables was $114006.0 in Q3 2025, with the low at $16306.0 in Q1 2025.
- The 5-year median for Receivables is $35843.5 (2023), against an average of $44555.9.
- The sharpest annual moves came in 2022 and 2025: Receivables tumbled 90.79% in 2022, then jumped 267.69% in 2025.
- Regenerative Medical Technology's Receivables stood at $49766.0 in 2022, then plunged by 51.86% to $23956.0 in 2023, then decreased by 5.64% to $22605.0 in 2024, then surged by 93.83% to $43815.0 in 2025, then retreated by 20.53% to $34821.0 in 2026.
- Business Quant data shows RMTG's Receivables at $34821.0 in Q1 2026, $43815.0 in Q4 2025, and $114006.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 8.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,821.00 |
| Dec 31, 2025 | 43,815.00 |
| Sep 30, 2025 | 114,006.00 |
| Jun 30, 2025 | 36,676.00 |
| Mar 31, 2025 | 16,306.00 |
| Dec 31, 2024 | 22,605.00 |
| Sep 30, 2024 | 31,006.00 |
| Jun 30, 2024 | 24,188.00 |
| Mar 31, 2024 | 43,506.00 |
| Dec 31, 2023 | 23,956.00 |
| Sep 30, 2023 | 35,011.00 |
| Jun 30, 2023 | 51,261.00 |
| Mar 31, 2023 | 102,761.00 |
| Dec 31, 2022 | 49,766.00 |
| Jun 30, 2022 | 23,027.00 |
| Mar 31, 2022 | 60,184.00 |
| Dec 31, 2021 | 34,513.00 |
| Sep 30, 2021 | 38,669.00 |
| Jun 30, 2021 | 250,000.00 |